Hap Trading, LLC Bridge Bio Pharma, Inc. Put Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $1.37 Million - $2.02 Million	50,000 New	50,000 $90 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $4.47 Million - $6.06 Million	336,700 New	336,700 $5.79 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $1,563 - $3,642	300 Added 1.47%	20,700 $64,000
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $3.23 Million - $7.55 Million	-440,000 Reduced 95.57%	20,400 $53,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $3.39 Million - $15.9 Million	298,000 Added 183.5%	460,400 $2.96 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $571,814 - $783,727	12,200 Added 8.12%	162,400 $1.63 Million
Q2 2021 Aug 11, 2021	BUY	$46.47 - $63.93 $4,647 - $6,393	100 Added 0.07%	150,200 $1.18 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $8.33 Million - $10.9 Million	150,100 New	150,100 $1.49 Million

295

170M

10.4M

2.36M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.5B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.